Presenter Biography

David M. Gamm, M.D., Ph.D.

Assistant Professor of Ophthalmology and Visual Sciences
University of Wisconsin-Madison

David M. Gamm, M.D., Ph.D., is an associate professor of Ophthalmology and Visual Sciences and the Emmett A. Humble Distinguished Director of the McPherson Eye Research Institute at the University of Wisconsin-Madison. He also holds the Sandra Lemke Trout Chair in Eye Research, and is a member of the Waisman Center Stem Cell Research Program and the UW Stem Cell and Regenerative Medicine Center. Dr. Gamm earned his M.D. and Ph.D. from the University of Michigan-Ann Arbor and completed his residency and pediatric ophthalmology fellowship at the University of Wisconsin, and was recently elected into the American Society for Clinical Investigation. Dr. Gamm diagnoses and manages a wide range of pediatric eye and vision disorders, including inherited retinal degenerations. However, most of his effort is directed toward stem cell research, where his primary interests lie in the study of mechanisms controlling the specification and maturation of specific retinal cell types, as well as the generation of retinal cell populations for use in the modeling and treatment of retinal degenerative diseases. Through collaborations with other FFB researchers, he is testing the ability of human pluripotent stem cells to rescue and replace retinal cells.

Keynote Speaker

• Michael Hingson, The Michael Hingson Group, Inc.

Presenters

• Isabelle Audo, M.D., PH.D., Quinze-Vingts Hospital
• Benjamin Bakall, Ph.D., University of Iowa
• William Beltran, D.V.M., Ph.D., School of Veterinary Medicine
• Eliot Berson, Massachusetts Eye and Ear Infirmary
• Kathy Blake
• Shannon Boye, University of Florida
• Rusty Bromley, Translational Research Acceleration via Consulting
• Tiffany Chan, O.D., Wilmer Eye Institute, Johns Hopkins University
• Charlie Collins, Vision Dynamics, LLC
• Stephen Daiger, University of Texas Health Science Center in Houston
• Arlene Drack
• Jacque L. Duncan, M.D., University of California, San Francisco
• Timothy Elder, TRE Legal Practice, LLC
• Gerald Fishman, M.D., The Chicago Lighthouse for People Who are Blind or Visually Impaired
• David M. Gamm, M.D., Ph.D., University of Wisconsin-Madison
• Duane R. Geruschat, Ph.D., Salus University
• Douglas Goist, National Industries for the Blind
• Michael Grassi
• James T. Handa, M.D., Wilmer Eye Institute, Johns Hopkins University
• Rod Haneline, Leader Dogs for the Blind
• Brian Hurley, National Industries for the Blind
• Christine Kay, M.D., University of Florida
• Mark E. Kleinman, M.D.
• Craig MacFarlane, Edward Jones Company
• Toni March, Office of Blindness and Vision Services, Division of Rehabilitation Services
• Michel Michaelides
• Muna Naash
• Mark Pennesi, M.D., Ph.D., Casey Eye Institute
• Darlene Peregoy, Office for Blindness and Vision Services, Division of Rehabilitation Services
• Eric Pierce, Massachusetts Eye and Ear Infirmary
• Dan Roberts, Macular Degeneration Support
• José-Alain Sahel, M.D.
• Philip Saunders
• Hendrik Scholl
• Everett T. Shupe II, MBA, CAE, CMP, Shupe Plans
• Janet Sunness, M.D., Hoover Low Vision Rehabilitation Services, Greater Baltimore Medical Center
• Karmen M Trzupek, MS, CGC, Informed Medical Decisions, Inc.
• Dawn E. Turco, Hadley School for the Blind
• Lou Tutt, Association for Education and Rehabilitation of the Blind and Visually Impaired
• Luk H. Vandenberghe, Ph.D., HMassachusetts Eye and Ear Infirmary and Harvard Medical School
• Douglas Walker, Hadley School for the Blind
• Richard G. Weleber, M.D., Casey Eye Institute, Oregon Health and Science University
• Dan Wenzel, Blind Industries and Services of Maryland
• Kim Walker, Tennessee School for the Blind
• Sandy White, Blind Sports Organization
• Paul Yang, M.D., Ph.D., University of Utah
• Donald Zack
• Michael Zuber